Search results

Search Web pagesPDFs

Results will auto-populate based on filter selection.

Filters
Forms
News Release
Operational Policy Manual
(-) Page
Keywords
FAQ
Forms
Provider profile
Found 626 result(s)
Drug formulary listing decision – Tapentadol extended release and tapentadol immediate release
Indication(s)Nucynta® ER is indicated for the management of pain that is severe enough to require daily, continuous, long-term opioid treatment, opioid-responsive; and for…
Drug formulary listing decision - Tramadol
Indication(s)Treatment of moderate to moderately severe pain.Formulary statusThe Drug Advisory Committee (DAC) recommended that tramadol be covered for people with workplace…
Drug formulary listing decision - Viscosupplements
Indication(s)Management of joint pain in osteoarthritis (OA) of the knee in those who have failed to respond to non-pharmacological treatment and trials of simple analgesics…
Drug formulary listing decision – Ziprasidone
Indication(s)Treatment of schizophrenia and related psychotic disorders, the treatment of acute manic or mixed episodes associated with bipolar disorder.DAC recommendationThe…
Empowering the next generation of students: Text transcript with description of visuals
AudioVisualUpbeat, inspiring background music is playingWSIB logoAmirah’s voice says: Innovation plays a really large role in the WSIB.Three people are congregating outside a…